New rules limiting the use of green tea extracts in the EU

Published 2021년 10월 21일

Tridge summary

The European Commission has proposed a draft regulation to limit the use of green tea extracts in food due to health concerns. The proposal is based on EFSA's opinion that high doses of epigallocatechin-3-gallate, found in green tea extracts, can damage the liver. The proposed regulation would prohibit the use of green tea extracts containing 800 mg or more of this compound, with some exceptions and labeling requirements. The regulation is currently open for public consultation and is expected to be implemented following its publication in the Official Journal of the European Union.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The European Commission (EC) has presented a draft legal act limiting the use of green tea extracts in food. The current version of the draft Commission Regulation does not provide for a transitional period. INTRODUCTION Several years ago, selected EU Member States and Norway presented studies showing that green tea extract containing epigallocatechin (-) - 3-gallate used in dietary supplements may be hazardous to health. The EC asked EFSA to prepare an opinion in this regard. EFSA concluded that traditionally prepared green tea infusion catechins and reconstituted drinks with an equivalent composition to traditional green tea infusions are generally considered safe under the presumption of safety principle, provided that the consumption corresponds to the reported consumption in the Member States. The average daily intake of (-) - epigallocatechin-3-gallate resulting from the consumption of green tea infusions ranges from 90 to 300 mg / day. EFSA also concluded, based on the ...

Source: Foodfakty